Aoxing Pharmaceutical Company, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €0.00 +NaN% €0.00 +NaN% N/A €0.00 +NaN% N/A
    €0.00 +NaN% €0.00 +NaN% N/A €0.00 +NaN% N/A
    €0.00 +NaN% €0.00 +NaN% N/A €0.00 +NaN% N/A
    €0.00 +NaN% €0.00 +NaN% N/A €0.00 +NaN% N/A
    €0.00 -100.0% €0.00 -100.0% N/A €0.00 -100.0% N/A
    €27.68M +26.9% €1.76M -62.5% 6.4% -0.15 pp -€357.10K -107.3% -1.3% -0.24 pp
    €21.81M +100.0% €4.70M -166.9% 21.6% +0.86 pp €4.91M -176.8% 22.5% +0.81 pp
    €10.91M +17.6% -€7.03M -51.1% -64.5% +0.91 pp -€6.39M -5.3% -58.6% +0.14 pp
    €9.27M +33.1% -€14.39M +6.2% -155.2% +0.39 pp -€6.74M +1,272.9% -72.7% -0.66 pp
    €6.96M +22.3% -€13.54M +113.5% -194.5% -0.83 pp -€491.23K -55.9% -7.1% +0.12 pp
    €5.69M +8.7% -€6.34M +790.7% -111.4% -0.98 pp -€1.11M -34.4% -19.5% +0.13 pp
    €5.24M -31.6% -€712.27K -66.1% -13.6% +0.14 pp -€1.70M -225.1% -32.4% -0.50 pp
    €7.66M +26.6% -€2.10M -167.2% -27.4% -0.79 pp €1.36M +216.6% 17.7% +0.11 pp
    €6.05M +264.4% €3.12M -194.0% 51.6% +2.5 pp €428.51K +1,045.4% 7.1% +0.048 pp
    €1.66M +∞% -€3.32M +156.4% -200.1% -2.0 pp €37.41K -105.9% 2.3% +0.023 pp
    €0.00 -100.0% -€1.30M +535.7% N/A -€628.85K +1,669.4% N/A
    €1.02M -€203.75K -19.9% -€35.54K -3.5%

    Notifications